PAR-13-025 in Selected Topics in Transfusion Medicine open until January 2017
PAR-13-002 for Clinical Trial Pilot Studies
PAR-13-128 for Multicenter Phase III Clinical Trials
BARDA CBRN BAA-12-100-SOL-00011: A Broad Agency Announcement (BAA) for advanced development of therapies for hematopoietic syndrome, bone marrow stromal cell loss, and vascular injury resulting from acute exposure to ionizing radiation
CLICK HERE to view NHLBI presentation “Supporting a Strategic Research Agenda in Transfusion Medicine” .